D-Index & Metrics Best Publications
Microbiology
Australia
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 85 Citations 23,387 289 World Ranking 228 National Ranking 7

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Australia Leader Award

2020 - Fellow of the Australian Academy of Health and Medical Science

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Gene
  • Internal medicine

Roy M. Robins-Browne mainly focuses on Microbiology, Virulence, Escherichia coli, Virology and Immunology. He has researched Microbiology in several fields, including Plasmid, Yersinia enterocolitica, Secretion, Enterobacteriaceae and Diarrhea. Roy M. Robins-Browne is investigating Virulence as part of his inquiry into Genetics and Gene.

His Escherichia coli study combines topics in areas such as Small intestine and Cecum. His biological study spans a wide range of topics, including Fimbria, Bacterial adhesin and Shiga toxin. His Immunology research is multidisciplinary, relying on both Probiotic, Cystic fibrosis and Pseudomonas aeruginosa.

His most cited work include:

  • Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. (1947 citations)
  • Emergence of multiply resistant pneumococci. (554 citations)
  • Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. (527 citations)

What are the main themes of his work throughout his whole career to date?

Roy M. Robins-Browne mainly investigates Microbiology, Virulence, Escherichia coli, Immunology and Enterobacteriaceae. His research in Microbiology intersects with topics in Plasmid, Yersinia enterocolitica, Bacteria, Virology and Enteropathogenic Escherichia coli. Roy M. Robins-Browne has included themes like Citrobacter rodentium and Regulation of gene expression in his Virulence study.

Roy M. Robins-Browne combines subjects such as Molecular biology and Diarrhea with his study of Escherichia coli. His study in Immunology is interdisciplinary in nature, drawing from both Internal medicine, Streptococcus pneumoniae and Tuberculosis. His studies deal with areas such as Pathogen and Intestinal mucosa as well as Enterobacteriaceae.

He most often published in these fields:

  • Microbiology (81.73%)
  • Virulence (37.82%)
  • Escherichia coli (27.66%)

What were the highlights of his more recent work (between 2011-2021)?

  • Microbiology (81.73%)
  • Immunology (26.14%)
  • Genetics (22.34%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Microbiology, Immunology, Genetics, Virulence and Streptococcus pneumoniae. His study of Pathogen is a part of Microbiology. The various areas that Roy M. Robins-Browne examines in his Immunology study include Disease and Tuberculosis.

The study incorporates disciplines such as Enterotoxin and Intimin in addition to Virulence. His Streptococcus pneumoniae study combines topics from a wide range of disciplines, such as Meningitis, Probiotic bacterium and Haemophilus influenzae. His research on Escherichia coli also deals with topics like

  • Genome which connect with Sequence analysis,
  • Whole genome sequencing and related In silico and Serotype.

Between 2011 and 2021, his most popular works were:

  • Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. (1947 citations)
  • Discovery of an archetypal protein transport system in bacterial outer membranes (157 citations)
  • Discovery of an archetypal protein transport system in bacterial outer membranes (157 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Gene
  • Internal medicine

His primary areas of study are Immunology, Microbiology, Escherichia coli, Enteropathogenic Escherichia coli and Diarrhea. His work on Allergy, Immune system, Gut flora and BCG vaccine as part of general Immunology study is frequently connected to Terminal restriction fragment length polymorphism, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Vaccination research extends to the thematically linked field of Microbiology.

His Escherichia coli study incorporates themes from Transport protein and Genome. His Enteropathogenic Escherichia coli study is related to the wider topic of Virulence. His Diarrhea study also includes fields such as

  • Epidemiology and related Etiology and Pediatrics,
  • Case-control study together with Cryptosporidium.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

Karen L. Kotloff;James P. Nataro;William C. Blackwelder;Dilruba Nasrin.
The Lancet (2013)

2642 Citations

Probiotic use in clinical practice: what are the risks?

Robert J Boyle;Roy M Robins-Browne;Mimi L K Tang.
The American Journal of Clinical Nutrition (2006)

1069 Citations

Emergence of multiply resistant pneumococci.

M R Jacobs;H J Koornhof;R M Robins-Browne;C M Stevenson.
The New England Journal of Medicine (1978)

873 Citations

Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.

James P. Nataro;James B. Kaper;Roy Robins-Browne;Valeria Prado.
Pediatric Infectious Disease Journal (1987)

715 Citations

Characterization of Enteroadherent-Aggregative Escherichia coli, a Putative Agent of Diarrheal Disease

Pablo A. Vial;Roy Robins-Browne;Hermy Lior;Valeria Prado.
The Journal of Infectious Diseases (1988)

407 Citations

Chips with everything: DNA microarrays in infectious diseases

Penelope A Bryant;Deon Venter;Roy Robins-Browne;Nigel Curtis.
Lancet Infectious Diseases (2004)

325 Citations

Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.

R M Robins-Browne;J K Prpic.
Infection and Immunity (1985)

315 Citations

Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells

Larissa Nicholls;Travis H. Grant;Roy M. Robins-Browne.
Molecular Microbiology (2000)

294 Citations

Traditional Enteropathogenic Escherichia coli of Infantile Diarrhea

Roy M. Robins-Browne.
Clinical Infectious Diseases (1987)

277 Citations

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.

Benjamin P Howden;Christopher R E McEvoy;David L Allen;Kyra Y L Chua;Kyra Y L Chua.
PLOS Pathogens (2011)

277 Citations

Editorial Boards

Pathology
(Impact Factor: 5.335)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Roy M. Robins-Browne

James P. Nataro

James P. Nataro

University of Virginia

Publications: 146

Myron M. Levine

Myron M. Levine

University of Maryland, Baltimore

Publications: 114

Gad Frankel

Gad Frankel

Imperial College London

Publications: 95

James B. Kaper

James B. Kaper

University of Maryland, Baltimore

Publications: 86

Timothy P. Stinear

Timothy P. Stinear

University of Melbourne

Publications: 66

Nigel Curtis

Nigel Curtis

Royal Children's Hospital

Publications: 62

Umesh D. Parashar

Umesh D. Parashar

Centers for Disease Control and Prevention

Publications: 59

B. Brett Finlay

B. Brett Finlay

University of British Columbia

Publications: 59

Helge Karch

Helge Karch

University of Münster

Publications: 59

Richard L. Guerrant

Richard L. Guerrant

University of Virginia

Publications: 58

David A. Rasko

David A. Rasko

University of Maryland, Baltimore

Publications: 56

Gagandeep Kang

Gagandeep Kang

Christian Medical College & Hospital

Publications: 56

Karen L. Kotloff

Karen L. Kotloff

University of Maryland, Baltimore

Publications: 54

Paul D R Johnson

Paul D R Johnson

Austin Health

Publications: 50

Keith P. Klugman

Keith P. Klugman

Bill & Melinda Gates Foundation

Publications: 48

Elizabeth L. Hartland

Elizabeth L. Hartland

Hudson Institute of Medical Research

Publications: 48

Trending Scientists

Shelly J. Lundberg

Shelly J. Lundberg

University of California, Santa Barbara

Anders Kristensen

Anders Kristensen

Technical University of Denmark

Guangdong Tian

Guangdong Tian

Shandong University

Marie-Paule Teulade-Fichou

Marie-Paule Teulade-Fichou

University of Paris-Saclay

Simone Raoux

Simone Raoux

Helmholtz-Zentrum Berlin für Materialien und Energie

Petra Van Damme

Petra Van Damme

Ghent University

Jan Moeyersons

Jan Moeyersons

Royal Museum for Central Africa

Timothy Peter Jones

Timothy Peter Jones

Cardiff University

Lennart Olsson

Lennart Olsson

Lund University

Constantini Samara

Constantini Samara

Aristotle University of Thessaloniki

Brian G. Heikes

Brian G. Heikes

University of Rhode Island

Nathalie Rouach

Nathalie Rouach

PSL University

Louis A. Matis

Louis A. Matis

Alexion Pharma (Switzerland)

Clifford M. Snapper

Clifford M. Snapper

Uniformed Services University of the Health Sciences

Miyuki Azuma

Miyuki Azuma

Tokyo Medical and Dental University

Oz Shy

Oz Shy

Federal Reserve Bank of Atlanta

Something went wrong. Please try again later.